VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filing Details

Document Details

Form
Filing Date
Sep 13, 2021
Document Date
Sep 9, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Vanda Pharmaceuticals Inc.
Issuer
Vanda Pharmaceuticals Inc.
Filer
Mitchell Stephen Ray
Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |